Assessment of high on-treatment platelet reactivity in patients with ischemic heart disease: Concordance between the Multiplate and VerifyNow assays

Journal of Thrombosis and Haemostasis

Volumn 11, Issue 2, 2013, Pages 379-381

  Consuegra Sanchez L ^a   Lopez Palop R ^b   Cano, P ^a   Carrillo, P ^b   Pico F ^a   Villegas, M ^a   Sanchis, J ^c   Kaski, J C ^d  

^a Hospital Universitario de Santa Lucia   (Spain)

^b HOSPITAL UNIVERSITARIO DE SAN JUAN   (Spain)

^c HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^d ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; CLOPIDOGREL;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; BLOOD ANALYSIS; COMPARATIVE STUDY; CONSENSUS; FEMALE; HOSPITAL INFORMATION SYSTEM; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; OUTCOME ASSESSMENT; PLATELET REACTIVITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REFERENCE VALUE;

ADENOSINE DIPHOSPHATE; AGED; ARACHIDONIC ACID; ASPIRIN; BLOOD PLATELETS; DRUG RESISTANCE; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PLATELET FUNCTION TESTS; PREDICTIVE VALUE OF TESTS; PURINERGIC P2Y RECEPTOR ANTAGONISTS; RECEPTORS, PURINERGIC P2Y12; REPRODUCIBILITY OF RESULTS; SPAIN; TICLOPIDINE; TREATMENT OUTCOME;

EID: 84873542541     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/jth.12073     Document Type: Article

References (11)

1. Bonello L, Tantry US, Marcucci R, Blindt R, Angiolillo DJ, Becker R, Bhatt DL, Cattaneo M, Collet JP, Cuisset T, Gachet C, Montalescol G, Jennings LK, Kereiakes D, Sibbing D, Trenk D, van Werkum JW, Paganelly F, Price MJ, Waksman R, et al. Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate. J Am Coll Cardiol 2010; 56: 919-33.
2. VerifyNow P2Y12 Assay Product Insert. San Diego. CA: Accumetrics. http://www.accumetrics.com/wpcontent/uploads/2011/10/VNP2Y12TestPro_Eng_ 14417C.pdf Accessed 25 September 2012.
3. Jeong YH, Kim IS, Choi BR, Kwak CH, Hwang JY. The optimal threshold of high post-treatment platelet reactivity could be defined by a point-of-care VerifyNow P2Y12 assay. Eur Heart J 2008; 29: 2186-7.
4. Sibbing D, Braun S, Morath T, Mehilli J, Vogt W, Schömig A, Kastrati A, von Beckerath N. Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis. J Am Coll Cardiol 2009; 53: 849.
5. Gurbel PA, Becker RC, Mann KG, Steinhubl SR, Michelson AD. Platelet function monitoring in patients with coronary artery disease. J Am Coll Cardiol 2007; 50: 1822-34.
6. Calatzis A, Spannagl M, Loreth R. Multiplate platelet function analysis-application and interpretation. http://www.multiplate.net.
7. VerifyNow Aspirin Assay Product Insert. San Diego, CA: Accumetrics. http://www.accumetrics.com/wp-content/uploads/2011/06/14314-rev-L_Eng.pdf. Accessed 25 September 2012.
8. Coleman JL, Wang JC, Simon DI. Determination of individual response to aspirin therapy using the Accumetrics Ultegra RFPA-ASA system. Point Care 2004; 3: 77-82.
9. van Werkum JW, Harmsze AM, Elsenberg EH, Bouman HJ, ten Berg JM, Hackeng CM. The use of the VerifyNow system to monitor antiplatelet therapy: a review of the current evidence. Platelets 2008; 19: 479-88.
10. Woo KS, Kim BR, Kim JI, Goh RY, Yu LH, Kim MH, Han JY. Determination of the prevalence of aspirin and clopidogrel resistances in patients with coronary artery disease by using various platelet-function tests. Korean J Lab Med 2010; 30: 460-8.
11. Ko YG, Suh JW, Kim BH, Lee CJ, Kim JS, Choi D, Hong MK, Seo MK, Youn TJ, Chae IH, Choi DJ, Yang Y. Comparison of 2 point-of-care platelet function tests, VerifyNow Assay and Multiplate Electrode Platelet Aggregometry, for predicting early clinical outcomes in patients undergoing percutaneous coronary intervention. Am Heart J 2011; 161: 383-90.